East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, “Cambrex”) will be exhibiting at the 2011 American Association of Pharmaceutical Sciences (AAPS) Meeting and Exposition, October 24-27 in Washington, DC. Attendees are invited to visit Cambrex’s booth to learn about the Company’s wide range of custom development and manufacturing services as well as several innovative technologies for the pharmaceutical industry.
Cambrex offers small molecule Active Pharmaceutical Ingredients (APIs) and process development services for proprietary APIs as well as technologies, including Camouflage® taste-masking technology, that enhances the efficacy of finished drug products. Camouflage® drug delivery technology will be the focus of AAPS. Camouflage® is a polymer resin-based drug delivery platform that provides improved drug stability, the ability to control drug release and taste-masking as its major benefits and is a novel approach to dealing with many critical aspects of drug delivery. Cambrex has assisted innovator and generic drug companies in the commercialization of a number of important orally-dosed drug products based on this technology and Camouflage® has been deployed in a variety of dosage forms.
Cambrex specializes in finished dosage form development to assist with the commercialization of products through its Cambrex Zenara facility located in Hyderabad, India. Cambrex Zenara provides high quality and competitively priced pharmaceutical drug product, formulation, development and manufacturing capabilities designed to accelerate commercialization of finished drug products for the pharmaceutical industry with specific expertise in Nicotine Replacement Therapy (NRT). In December 2010, Cambrex Zenara began supplying an NRT product to support a commercial launch in the Indian market.
Cambrex will also be showcasing its global development and manufacturing capabilities including specialized offerings related to DEA controlled substances, high potency APIs and high energy chemistries. Cambrex manufactures over 120 generic and branded APIs and advanced intermediate products for the pharmaceutical and biopharma industry.
Cambrex will be exhibiting at Booth 1146 at the Walter E. Washington Convention Center, Washington, DC.